Ep 69: Guest Monty Pal
Melanoma Matters24 Jun 2025

Ep 69: Guest Monty Pal

Summary


In this episode, Sapna Patel and James Larkin engage with Monty Pal from City of Hope, discussing his unique journey into oncology, the significance of the microbiome in cancer treatment, and the impact of diet and lifestyle on patient outcomes. They explore current research, including clinical trials involving fecal microbiome transplants and the potential of specific bacteria to enhance immunotherapy effectiveness. The conversation highlights the evolving landscape of cancer treatment and the promising future of microbiome research in oncology.


Keywords

oncology, microbiome, cancer treatment, immunotherapy, diet, clinical trials, kidney cancer, melanoma, fecal microbiome transplant, City of Hope


Takeaways

Monty Pal started college at the age of 13, showcasing an unconventional path to medicine.

His journey into oncology was influenced by a pivotal decision to switch from engineering to medicine

Monty has significantly contributed to the growth of the GU oncology program at City of Hope.

The microbiome plays a crucial role in predicting patient outcomes and side effects in cancer treatment.

Dietary fiber intake has been linked to improved clinical outcomes in melanoma patients receiving immunotherapy.

Random probiotics may not be beneficial and could even be harmful to patients.

Research indicates that specific bacteria can enhance the effectiveness of immunotherapy.

The future of cancer treatment may involve turning cold tumors into hot tumors using microbiome interventions.


Titles

The Journey of Monty Pal: From Prodigy to Oncologist

Microbiome and Cancer: Turd Burglars to Treatment


Sound Bites

"I started college when I was 13."

"Fiber seems to be somewhat interesting."


Chapters

00:00 Introduction and Introduction of Monty Pal from City of Hope

01:42 Monty's Journey to Medicine

05:19 GU Oncology at City of Hope

10:28 The Microbiome: A New Frontier in Oncology

14:52 Microbiome Research and Clinical Outcomes

19:21 Lifestyle Factors and the Microbiome

23:51 Intervention Strategies: Fecal Microbiome Transplant and Beyond

24:35 South Park Episode: Turd Burglars

29:58 An Upcoming SWOG trial

32:48 Fact Check

Episoder(84)

Ep 81: IGNYTE trial (RP1 + nivo)

Ep 81: IGNYTE trial (RP1 + nivo)

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...

13 Feb 32min

Ep 80: 2025 Holiday Special

Ep 80: 2025 Holiday Special

SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...

30 Des 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up

Ep 79: coBRIM, COMBI-d 5-year follow-up

SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...

29 Des 202536min

Ep 78 TRAILER: MEK inhibitor trials

Ep 78 TRAILER: MEK inhibitor trials

Enjoy this short trailer on MEK inhibitor monotherapy trials in melanoma

29 Des 20251min

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

SummarySo many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib...

29 Des 202537min

Ep 77: Guest Merrick Ross

Ep 77: Guest Merrick Ross

SummaryIn this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Merrick Ross, a seasoned surgical oncologist, discussing his background, the evolution of surgical practice w...

29 Des 202544min

Ep 76: KEYNOTE 054 7-year follow-up

Ep 76: KEYNOTE 054 7-year follow-up

SummaryIn this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054There's a bit too...

28 Des 202528min

Ep 75: Immune-mediated Myocarditis

Ep 75: Immune-mediated Myocarditis

SummaryIn this (longest to-date) episode, James and Sapna delve into the not-so-rare occurence of immune-mediated myocarditis, particularly in the context of immune checkpoint inhibitors. The hosts di...

28 Des 20251h 4min

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
foreldreradet
rss-lopedrommen
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
hormonelle-frida
klimaks
treningsprat
g-punktet
rss-femihelse
rss-maren-mina
sinnsyn